NATH:NASDAQNathan's Famous, Inc. Analysis
Data as of 2026-05-26 - not real-time
$101.07
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Nathan's Famous (NATH) is trading at $101.07, essentially flat against its 20‑day, 50‑day and 200‑day moving averages (~$101), indicating a neutral price stance. The 14‑day RSI sits at 51.5, confirming the lack of momentum extremes. A bearish MACD histogram (‑0.0046) and a decreasing volume trend suggest short‑term pressure despite the stable averages. The stock’s beta of roughly 0.3 and 30‑day volatility under 6% point to low market‑risk exposure. However, the Fear & Greed Index at 91.8 signals heightened market optimism that could inflate price expectations. Fundamentally, revenue grew 9% YoY to $158 M with a solid 15% operating margin, supporting the current earnings multiple of 19.4× PE.
The discounted cash‑flow model values the company at about $82 per share, well below the market price, flagging an overvaluation gap. The dividend yield of 1.98% and a payout ratio of 38% are backed by $19 M of free cash flow, suggesting the dividend is sustainable. A negative book value per share (‑$3.73) drives an anomalous price‑to‑book of ‑27, highlighting balance‑sheet weakness. Net debt of roughly $29 M (debt $53 M less cash $24 M) is modest relative to the $414 M market cap, limiting financial distress risk. The decreasing trading volume (≈11 k today versus 10‑day average of 18.8 k) raises a moderate liquidity concern. Overall, the mix of steady earnings, attractive dividend and low beta is offset by an elevated price relative to intrinsic value, implying a cautious stance.
The discounted cash‑flow model values the company at about $82 per share, well below the market price, flagging an overvaluation gap. The dividend yield of 1.98% and a payout ratio of 38% are backed by $19 M of free cash flow, suggesting the dividend is sustainable. A negative book value per share (‑$3.73) drives an anomalous price‑to‑book of ‑27, highlighting balance‑sheet weakness. Net debt of roughly $29 M (debt $53 M less cash $24 M) is modest relative to the $414 M market cap, limiting financial distress risk. The decreasing trading volume (≈11 k today versus 10‑day average of 18.8 k) raises a moderate liquidity concern. Overall, the mix of steady earnings, attractive dividend and low beta is offset by an elevated price relative to intrinsic value, implying a cautious stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near key support level
- Bearish MACD histogram
- Decreasing trading volume
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Market price exceeds DCF fair value
- Elevated Fear & Greed index suggesting over‑optimism
- Negative book value and high price‑to‑book ratio
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Consistent revenue growth and solid operating margins
- Sustainable dividend backed by free cash flow
- Low beta and low volatility reducing market risk
Key Metrics & Analysis
Financial Health
Revenue Growth8.90%
Profit Margin13.59%
P/E Ratio19.4
ROA39.87%
P/B Ratio-27.1
Op. Cash Flow$22.5M
Free Cash Flow$19.2M
Technical Analysis
TrendNeutral
RSI51.5
Support$99.77
Resistance$101.74
MA 20$100.92
MA 50$100.91
MA 200$101.20
MACDBearish
VolumeDecreasing
Fear & Greed Index91.8
Valuation
Fair Value$82.11
GradeOvervalued
TypeBlend
Dividend Yield1.98%
Risk Assessment
Beta0.44
Volatility5.98%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.